News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
20 Results
Section
Business (2)
Drug Development (6)
News (8)
Tag
Alliances (2)
Clinical research (5)
Events (4)
Phase 1 (3)
Phase 2 (2)
Preclinical (1)
Date
2022 (1)
2021 (2)
2020 (1)
2018 (2)
2017 (6)
2015 (2)
2013 (1)
2011 (2)
Location
Asia (4)
Europe (15)
20 Results for "pharmaleads".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Promotion of a New Management Team at Pharmaleads to Accelerate the Development of Its Pain Relief Drug Candidates
Pharmaleads, a biopharmaceutical company specialized in the development of innovative pain relief products, announces the promotion of Tanja Ouimet as Chief Operating Officer and Hervé Poras as Chief Scientific Officer.
January 5, 2021
·
4 min read
Pharmaleads to present at BioTrinity 2018 in London
Pharmaleads will present at BioTrinity 2018 in London on Tuesday, April 24th at 3.35pm.
April 20, 2018
·
1 min read
Biotech Bay
Pharmaleads to Present at Biotech Showcase 2018 in San Francisco
Pharmaleads today announces its participation at the upcoming 10th Annual Biotech Showcase Conference to be held in San Francisco on January 8 - 10, 2018.
January 3, 2018
·
1 min read
Biotech Beach
IACTA Pharmaceuticals and Pharmaleads to Develop the World’s First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain
- Ocular Pain, a $10+ billion global market, with significant unmet medical need - License agreement aims to accelerate global development of DENKIs, leveraging expertise and resources of both companies
January 7, 2021
·
6 min read
Pharmaleads CEO to Present at Bio-Europe 2017
This year’s BIO-Europe conference will take place from 6-8 November at CityCube in Berlin, Germany.
November 6, 2017
·
1 min read
Pharmaleads To Present PL265 For Ocular Pain Results At The Association for Research in Vision & Ophthalmology 2017 Annual Meeting In Baltimore
May 5, 2017
·
3 min read
Drug Development
Pharmaleads Reports Positive Phase I SAD Data With Its Dual Enkephalinase Inhibitor (DENKI) PL265 For The Treatment Of Neuropathic Pain
June 29, 2017
·
3 min read
Drug Development
Pharmaleads Reports Positive Phase I SAD Data With Its Dual Enkephalinase Inhibitor (DENKI) PL265 For The Treatment Of Neuropathic Pain
June 29, 2017
·
3 min read
Drug Development
Pharmaleads Reports Positive Ocular Pain Results With PL265, A Novel Dual Enkephalinase Inhibitor (DENKI), At The Association for Research in Vision & Ophthalmology 2017 Annual Meeting
May 12, 2017
·
4 min read
Pharmaleads Reports Positive Ocular Pain Results With PL265, A Novel Dual Enkephalinase Inhibitor (DENKI), At The Association for Research in Vision & Ophthalmology 2017 Annual Meeting
May 12, 2017
·
4 min read
1 of 2
Next